Dr. Otto S. Lin, MD

Dr. Lin practices at Virginia Mason Medical Center - HOPD in Seattle, Washington.

Dr. Lin's NPI, 1841302650, was assigned on August 31, 2006. Dr. Lin graduated from Harvard Medical School in 1994. Dr. Lin holds Washington license MD00039421.

Dr. Lin's primary practice is Virginia Mason Medical Center - HOPD, at 1100 9th Ave, Seattle, WA 98101.

Dr. Lin's primary practice is Virginia Mason Medical Center - HOPD in Seattle, Washington. Dr. Lin is also affiliated with Virginia Mason Medical Center. The medical group on file is Franciscan Orthopedics - Silverdale. Dmand AI also links Dr. Lin to 3 more group practices and clinics, 2 medical groups and 1 imaging center, each named with a free account. Dr. Lin's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lin practices, 6 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Lin's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Lin is licensed in Washington.

CMS data shows 341 Medicare services from Dr. Lin across 11 procedure codes in 2024, for 290 Medicare patients. Medicare paid $40,720 for them.

CMS counts 290 Medicare patients who saw Dr. Lin in 2024. The largest group is 65 to 74, with 153 patients. 61% of them have high cholesterol, and 53% have high blood pressure. 7% are also on Medicaid. Their average risk score is 1.12, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Lin's median patient age at 68, with 46% women.

In 2024, Dr. Lin wrote 875 Medicare Part D claims for 321 patients. 79% of them were for generic drugs. CMS names the drug for 695 of them, across 18 drugs with 11 or more claims each, at $100,220 in total drug cost. In 2023, CMS named 669 claims across 15 drugs.

Dr. Lin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lin as offering telehealth. CMS counts 52 procedures of colonoscopy by Dr. Lin, more than 64% of the clinicians it reports for that procedure.

Dmand AI links 33 papers to Dr. Lin, published from 2005 to 2024. 2015 was the busiest year, with 4. The most frequent topics are Colonoscopy, Colorectal Neoplasms and Adenoma. Dr. Lin has published most often in Gastrointest Endosc. Dr. Lin's most frequent co-authors are Richard A. Kozarek, MD, Michael Gluck, MD and Michael V. Chiorean, MD.

CMS Open Payments shows 10 general payments to Dr. Lin from 7 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Medtronic USA, Inc. paid the most, $190.

Dr. Lin graduated from Harvard Medical School in 1994.